Nelarabine: a novel purine antimetabolite antineoplastic agent.

MLA

Buie, Larry W., et al. “Nelarabine: A Novel Purine Antimetabolite Antineoplastic Agent.” Clinical Therapeutics, vol. 29, no. 9, Sept. 2007, pp. 1887–99. EBSCOhost, https://doi.org/10.1016/j.clinthera.2007.09.002.

APA

Buie, L. W., Epstein, S. S., & Lindley, C. M. (2007). Nelarabine: a novel purine antimetabolite antineoplastic agent. Clinical Therapeutics, 29(9), 1887–1899. https://doi.org/10.1016/j.clinthera.2007.09.002

Chicago

Buie, Larry W, Stacy S Epstein, and Celeste M Lindley. 2007. “Nelarabine: A Novel Purine Antimetabolite Antineoplastic Agent.” Clinical Therapeutics 29 (9): 1887–99. doi:10.1016/j.clinthera.2007.09.002.